Severe acute respiratory disease is associated with chronic secondary infections that
exacerbate symptoms and mortality. So far, many drugs have been introduced to treat this …

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has resulted in dramatic worldwide mortality. Along with developing …

The recent pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
causative agent of Coronavirus Disease 2019 (COVID-19) has introduced itself into the …

Patients with Hantavirus-caused epidemic hemorrhagic fever (EHF) are at risk of contracting
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there is currently …

Lung-secreted IgG and IgM antibodies are valuable biomarkers for monitoring the local
immune response against respiratory infections. These biomarkers are found in lower …

SARS-CoV-2, the coronavirus triggering the disease COVID-19, has a catastrophic health
and socioeconomic impact at a global scale. Three key factors contribute to the …

The bronchial vascular endothelial network plays important roles in pulmonary pathology
during respiratory viral infections, including respiratory syncytial virus (RSV), influenza A …

The outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) signifies a serious worldwide concern to public health. Both transcriptome …

The hallmark of the coronavirus disease 2019 (COVID‐19) pathophysiology was reported to
be an inappropriate and uncontrolled immune response, evidenced by activated …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection significantly
affects the cardiovascular system, causing vascular damage and thromboembolic events in …